
A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device
|
|||||
![]() A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device ![]() The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes ![]() Two biotechnology and health technology companies are discovering precision treatments for neurological disorders with simulation models for individual patients. . . . → Read More: AI-Aided Collaboration to Discover Neuro Disease Drugs ![]() A software company is partnering with a psychologist to explore virtual reality working with mindfulness for relieving pain in cancer patients. . . . → Read More: Virtual Reality Studied for Chronic Cancer Pain ![]() Researchers in Europe and the U.S. are investigating gut processes in pigs to reduce antibiotics commonly used against infections, a source of antibiotic resistance. . . . → Read More: Intl. Team Studying Antibiotic Overuse in Pigs ![]() A collaboration between developers of protein analytics and test-strip diagnostics aims to create a quicker, more sensitive, easy-to-use Covid-19 detection test. . . . → Read More: Partnership Developing Faster, Sensitive Covid-19 Test ![]() Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership. . . . → Read More: Ginkgo Acquires Bayer Agricultural Biologics Technology ![]() A developer of new treatments for the inherited lung disease cystic fibrosis emerged from stealth mode, raising $111 million in new venture funds. . . . → Read More: Cystic Fibrosis Start-Up Raises $111M in New Funds ![]() A developer of therapies from engineered microbes is collaborating with a synthetic biology components company on tools to create engineered gut bacteria. . . . → Read More: Synthetic Bio Companies Partner on Therapeutic Microbes ![]() A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics. . . . → Read More: Biotech, Synthetic Bio Companies Partner on T-Cell Therapies |
|||||
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |